ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,291.68
0.36%
Dow Jones
44,612.04
0.71%
Gold vs US Dollar
2,630.945
-3.11%
Brent Oil
72.83
-2.59%
Bitcoin
95,306.52
-2.79%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX
  6. Novo Resources Corp (NVO)

  7. Novo Resources Corp (NVO) News

Novo Resources (NVO)

Novo Resources Corp
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:NVO
DateTimeSourceHeadlineSymbolCompany
28/08/202316:14PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NVO.WTTSX:NVONovo Resources Corp
28/08/202316:10PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - NVO.WTTSX:NVONovo Resources Corp
05/02/202114:00PR Newswire (Canada)TMX Group Equity Financing Statistics - January 2021TSX:NVONovo Resources Corp
16/02/201013:00PR Newswire (US)Novo Nordisk Makes Victoza(R) Commercially Available in the United StatesNYSE:NVO
21/01/201020:49PR Newswire (US)Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'NYSE:NVO
14/01/201008:01PR Newswire (US)Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper DemonstratesNYSE:NVO
13/01/201014:43PR Newswire (US)/K I L L K I L L K I L L - National Changing Diabetes Program/NYSE:NVO
13/01/201005:01PR Newswire (US)Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper DemonstratesNYSE:NVO
02/12/200914:00PR Newswire (US)FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to MenopauseNYSE:NVO
27/11/200914:30PR Newswire (US)Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study ShowsNYSE:NVO
27/11/200905:01PR Newswire (US)Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study ShowsNYSE:NVO
19/11/200913:00PR Newswire (US)Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results ShowNYSE:NVO
30/10/200913:00PR Newswire (US)Novo Nordisk is Changing Possibilities in HemophiliaNYSE:NVO
20/10/200912:30PR Newswire (US)Data Analysis Reinforces the Safety Profile of Levemir(R)NYSE:NVO
01/09/200913:58PR Newswire (US)Research Supports Improving 'Scoring' of Costs and Benefits of Preventive Health Care to Better Inform Federal Budgetary DecisioNYSE:NVO
01/09/200912:00PR Newswire (US)National Changing Diabetes Program Supports Improvements in Health Cost EstimatesNYSE:NVO
27/08/200913:03PR Newswire (US)Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their FamiliesNYSE:NVO
12/08/200914:00PR Newswire (US)Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and DiabetesNYSE:NVO
10/08/200913:00PR Newswire (US)Photos: Norditropin NordiFlex(R) 30 mg/3 mL Prefilled Pen Offers Children Needing a Larger Dose of Growth Hormone a Convenient ONYSE:NVO
05/08/200912:30PR Newswire (US)Novo Nordisk Appoints Per Falk, M.D., Ph.D., as Vice President for Clinical, Medical and Regulatory Affairs for North AmericaNYSE:NVO
23/07/200913:00PR Newswire (US)NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and CareNYSE:NVO
15/07/200917:43PR Newswire (US)FDA Approves NovoLog(R) Labeling UpdateNYSE:NVO
13/07/200917:51PR Newswire (US)Diabetes Advocates Call For National Strategy, Leadership to Reduce Diabetes and Advance Detection and TreatmentNYSE:NVO
28/06/200919:18PR Newswire (US)Novo Nordisk Insulin Analogs Have Proven Safety ProfilesNYSE:NVO
13/06/200917:09PR Newswire (US)Novo Nordisk Warns Customers About Stolen InsulinNYSE:NVO
12/06/200914:25PR Newswire (US)Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media SummitNYSE:NVO
08/06/200921:50PR Newswire (US)The Lancet Publishes Direct Comparison Study Between Liraglutide and ExenatideNYSE:NVO
08/06/200912:00PR Newswire (US)Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than GlimepirideNYSE:NVO
07/06/200914:00PR Newswire (US)Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162NYSE:NVO
20/05/200917:21PR Newswire (US)Americans Who Don't Know They Have Diabetes Incur $18 Billion in Health Expenses Each YearNYSE:NVO
 Showing the most relevant articles for your search:TSX:NVO

Your Recent History

LSE
VAST
Vast Resources
LSE
GWMO
Great Western Mining
LSE
POS
Plexus
LSE
ITV
Itv
LSE
SYME
Supply@me Capital
LSE
MTRO
Metro Bank
LSE
TW.
Taylor Wimpey
LSE
HVO
Hvivo
LSE
HOC
Hochschild Mining
LSE
QED
Quadrise
LSE
SCLP
Scancell
LSE
ECR
Ecr Minerals
LSE
ZED
Zenova
LSE
CPX
Cap-xx
LSE
GGP
Greatland Gold
LSE
AAZ
Anglo Asian Mining
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Silver

    1 year 40%, 2 years 50% and *3 years 60%

    *Across 3 years £903.96 only 361.58